BiomX Inc.’s filing revealed that its Chief Business Officer Oron Assaf acquired Company’s shares for reported $872.0 on May 22. In the deal valued at $0.27 per share,3,192 shares were bought. As a result of this transaction, Oron Assaf now holds 10,914 shares worth roughly $ 4147.32.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Oron Assaf bought 6,521 shares, generating $1,832 in total proceeds. Upon buying the shares at $0.28, the Chief Business Officer now owns 7,722 shares.
Before that, Oron Assaf bought 1,201 shares. BiomX Inc. shares valued at $328 were divested by the Chief Business Officer at a price of $0.27 per share. As a result of the transaction, Oron Assaf now holds 1,201 shares, worth roughly $456.38.
Ladenburg Thalmann initiated its BiomX Inc. [PHGE] rating to a Buy in a research note published on Friday, April 15, 2021; the price target was $25. PT values the company’s stock at a premium of 98.48 to its Friday closing price.
Price Performance Review of PHGE
On Friday, BiomX Inc. [AMEX:PHGE] saw its stock fall -5.00% to $0.38. On the same session, the stock had its day’s lowest price of $0.38, but rose to a high of $0.42. Over the last five days, the stock has lost -2.56%. BiomX Inc. shares have risen nearly 103.54% since the year began. Nevertheless, the stocks have fallen -30.91% over the past one year. While a 52-week high of $0.69 was reached on 03/01/23, a 52-week low of $0.13 was recorded on 01/03/23. SMA at 50 days reached $0.3899, while 200 days put it at $0.3216. A total of 65835.0 shares were traded, compared to the trading of 0.23 million shares in the previous session.
Levels Of Support And Resistance For PHGE Stock
The 24-hour chart illustrates a support level at 0.3666, which if violated will result in even more drops to 0.3531. On the upside, there is a resistance level at 0.4069. A further resistance level may holdings at 0.4337. The Relative Strength Index (RSI) on the 14-day chart is 46.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0128, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.75%. Stochastics %K at 68.84% indicates the stock is a holding.
How much short interest is there in BiomX Inc.?
A steep rise in short interest was recorded in BiomX Inc. stocks on Aug 14, 2023, dropping by 5490.0 shares to a total of 6370.0 shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 11860.0 shares. There was a decline of -86.19%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.01% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.07.
BiomX Inc. [PHGE] – Who Are The Largest Shareholders?
In filings from MM Asset Management, Inc., it is revealed that the company now owns 644,449 shares, or roughly 1.40% of the outstanding PHGE shares. In other words, the investor’s shares have risen by 36,287 from its previous 13-F filing of 608162.0. Additionally, Renaissance Technologies LLC increased 149.67% of its stake after which the total value it holdings stand at $84,063. At present, Walleye Capital LLC is holding 31,478 shares valued at $13536.0. G1 Execution Services LLC owned 0 shares of the company at the time of its most recent 13F filing, worth $0.0.
According to FactSet, BiomX Inc.’s share price will average $5.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 1275.0 percent from its previous closing price of $0.40. Analysts expect BiomX Inc. stock to reach the higher price of $7.00, while the lowest price estimate is $4.00. However, 2 analysts have rated PHGE stock as a Buy in their predictions for 2023.